title: Hospital readmissions in patients with inflammatory bowel disease.
abstract: OBJECTIVE
  We aimed to identify the frequency and costs of, and the disease predictors and inpatient process issues that may predispose to, 30-day readmission for an inflammatory bowel disease (IBD) patient.
  
  
  METHODS
  IBD patients admitted to an inpatient gastroenterology service were followed for a time-to-readmission analysis assessing factors associated with readmission within 30 days.
  
  
  RESULTS
  Index admissions were more costly among those readmitted than among those not readmitted. Patients admitted with evidence of increased inflammation, infection, or obstruction or for dehydration or pain control had a higher risk of readmission. Patients treated with opioid analgesia during index admission were no less likely to be readmitted, and there was a 2.2-fold increase in readmissions when patients were discharged with no opioid analgesia. Scheduling variability and outpatient follow-up compliance were associated with readmission.
  
  
  CONCLUSIONS
  Predicting readmission is complex. A predictive model developed to be used at discharge yielded an area under the curve of 0.757.
authors.affiliation: Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
authors.forename: Nyla
authors.initials: N
authors.lastname: Hazratjee
authors.forename: Markus
authors.initials: M
authors.lastname: Agito
authors.forename: Rocio
authors.initials: R
authors.lastname: Lopez
authors.forename: Bret
authors.initials: B
authors.lastname: Lashner
authors.forename: Maged K
authors.initials: MK
authors.lastname: Rizk
mesh_terms: D018784:Abdominal Abscess / Q000000981:diagnostic imaging / Q000209:etiology / Q000601:surgery; D015746:Abdominal Pain / Q000209:etiology; D000328:Adult; D000701:Analgesics, Opioid / Q000627:therapeutic use; D001071:Appointments and Schedules; D019540:Area Under Curve; D001569:Benzodiazepines / Q000627:therapeutic use; D003681:Dehydration / Q000209:etiology; D016099:Endoscopy, Gastrointestinal; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000191:economics / Q000628:therapy*; D007415:Intestinal Obstruction / Q000000981:diagnostic imaging / Q000209:etiology; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D010347:Patient Care Planning; D010349:Patient Compliance; D010359:Patient Readmission / Q000191:economics / Q000706:statistics & numerical data*; D016016:Proportional Hazards Models; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D055815:Young Adult
chemical_list: D000701:Analgesics, Opioid; D001569:Benzodiazepines